Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -14.69%15.66M | 49.30%20.17M | 86.96%25.55M | 46.05%60.6M | 19.29%14.92M | 88.27%18.35M | 53.15%13.51M | 31.22%13.67M | 7.17%41.49M | 12.51M |
| Cost of revenue | -54.14%2.8M | 8.32%3.42M | -35.73%2.93M | 64.63%17.26M | -18.95%3.44M | 186.01%6.11M | 59.27%3.16M | 114.20%4.56M | 34.97%10.49M | 4.24M |
| Gross profit | 5.01%12.85M | 61.80%16.75M | 148.31%22.63M | 39.77%43.34M | 38.89%11.48M | 60.83%12.24M | 51.37%10.35M | 9.93%9.11M | 0.19%31.01M | 8.27M |
| Operating expense | 15.21%5.83M | 17.02%5.6M | 17.43%5M | 26.18%19.66M | 46.08%5.56M | 27.64%5.06M | 17.63%4.78M | 10.43%4.26M | 16.77%15.58M | 3.8M |
| Selling and administrative expenses | 27.03%5.32M | 18.81%5.23M | 17.05%4.65M | 21.86%17.9M | 49.96%5.33M | 19.03%4.18M | 12.67%4.4M | 7.09%3.97M | 14.40%14.69M | --3.56M |
| -Selling and marketing expense | 0.75%2.69M | 20.26%3.06M | 22.61%2.81M | 38.99%10.82M | 72.61%3.31M | 24.27%2.67M | 46.72%2.55M | 15.53%2.29M | 15.13%7.78M | --1.92M |
| -General and administrative expense | 73.28%2.63M | 16.81%2.17M | 9.46%1.84M | 2.55%7.08M | 23.48%2.03M | 10.82%1.52M | -14.55%1.86M | -2.61%1.68M | 13.59%6.91M | --1.64M |
| Other operating expenses | -41.47%511K | -3.67%367K | 22.65%352K | 76.25%1.76M | -9.72%223K | 95.30%873K | 139.62%381K | 93.92%287K | 68.12%1M | --247K |
| Total other operating income | ---- | ---- | ---- | -96.14%4.2K | ---- | ---- | ---- | ---- | 18.77%108.77K | ---- |
| Operating profit | -2.17%7.03M | 100.29%11.15M | 263.12%17.63M | 53.50%23.68M | 32.76%5.93M | 96.88%7.18M | 100.87%5.57M | 9.50%4.85M | -12.38%15.42M | 4.46M |
| Net non-operating interest income (expenses) | -9.53%389K | 17.11%438K | -2.22%353K | 0.79%816.02K | 3.38%367K | -5.70%430K | 214.29%374K | 455.38%361K | 2,184.95%809.65K | 355K |
| Non-operating interest income | -9.28%391K | 16.80%438K | -2.49%353K | -18.07%819.21K | 3.09%367K | -5.90%431K | 47.06%375K | 212.07%362K | 565.65%999.92K | --356K |
| Non-operating interest expense | 100.00%2K | --0 | --0 | -98.32%3.19K | --0 | -50.00%1K | -99.26%1K | -98.04%1K | 0.65%190.27K | --1K |
| Net investment income | -98.42%8.53K | 37.01%539.03K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 314.32%772.97K | 186.56K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | -45.71%167.2K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 45.71%-167.2K | ---- |
| Other non-operating income (expenses) | 1,300.00%70K | 908.11%373K | -68.75%50K | -0.01%146.07K | -95.00%14K | -95.33%5K | -89.34%37K | -29.82%160K | 472.78%146.09K | 280K |
| Income before tax | -1.73%7.49M | 100.08%11.96M | 235.42%18.03M | 47.17%25.42M | 23.70%6.31M | 80.88%7.62M | 84.65%5.98M | 13.73%5.38M | -5.57%17.27M | 5.1M |
| Income tax | 26.40%2.34M | 130.17%3.35M | 234.74%4.38M | 32.68%5.69M | -27.63%1.08M | 118.65%1.85M | 63.48%1.46M | 23.07%1.31M | -1.82%4.29M | 1.49M |
| Net income | -10.77%5.14M | 90.41%8.61M | 235.64%13.65M | 51.95%19.73M | 44.91%5.23M | 71.37%5.77M | 92.67%4.52M | 11.03%4.07M | -6.75%12.98M | 3.61M |
| Net income continuous operations | -10.77%5.14M | 90.41%8.61M | 235.64%13.65M | 51.95%19.73M | 44.91%5.23M | 71.37%5.77M | 92.67%4.52M | 11.03%4.07M | -6.75%12.98M | --3.61M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -10.77%5.14M | 90.41%8.61M | 235.64%13.65M | 51.95%19.73M | 44.91%5.23M | 71.37%5.77M | 92.67%4.52M | 11.03%4.07M | -6.75%12.98M | 3.61M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -10.77%5.14M | 90.41%8.61M | 235.64%13.65M | 51.95%19.73M | 44.91%5.23M | 71.37%5.77M | 92.67%4.52M | 11.03%4.07M | -6.75%12.98M | 3.61M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -11.43%0.0093 | 90.24%0.0156 | 235.14%0.0248 | 42.63%0.0358 | 43.94%0.0095 | 72.13%0.0105 | 90.70%0.0082 | 11.18%0.0074 | -0.76%0.0251 | 0.0066 |
| Diluted earnings per share | -11.43%0.0093 | 90.24%0.0156 | 235.14%0.0248 | 42.63%0.0358 | 43.94%0.0095 | 72.13%0.0105 | 90.70%0.0082 | 11.18%0.0074 | -0.76%0.0251 | 0.0066 |
| Dividend per share | 0.00%0.02 | 0.02 | 0.02 | 0.00%0.02 | 0 | 0.00%0.02 | 0 | 0 | 0.02 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.